New research suggests exercise during chemotherapy may help protect cognitive function, offering hope for patients struggling ...

A non-profit partnered with Boardman Junior High School to help those fighting cancer. It’s called a “Blessed Bag,” and it ...

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...

San Antonio teamed up with Angeles Sin Fronteras to provide free wigs and cosmetic kits to local cancer patients undergoing ...

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

Early and late responders with esophageal squamous cell carcinoma experienced comparable OS benefits with Tevimbra plus chemo ...

Managing maximum tolerated dose (MTD) chemotherapy while minimizing neutropenia relies on precise complete blood count (CBC) monitoring and AI-powered diagnostics.

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

Dr. Julia Compton looks over scans at Hancock Regional Hospital. Construction will soon start to double the number of chairs at Sue Ann Wortman Cancer Center’s infusion center. GREENFIELD ...

Among patients with chemotherapy-induced peripheral neuropathy, those treated with platinum-based agents, taxanes had highest prevalence. (HealthDay News) — The pooled prevalence of chronic ...

Patients treated with platinum-based agents ... of chronic painful neuropathy is 41.2% among individuals with chemotherapy-induced peripheral neuropathy (CIPN), according to a meta-analysis ...